Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uncoupling protein-2 promotes nigrostriatal dopamine neuronal function.

Zane B Andrews1, Alicia Rivera, John D Elsworth

  • 1Department of Obstetrics, Gynecology & Reproductive Services, Yale University School of Medicine, New Haven, CT 06510, USA.

The European Journal of Neuroscience
|August 3, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HAPTI-Child: a finger-tracking video and keypoint dataset of haptic picture exploration and identification in congenitally blind and visually impaired children.

Frontiers in psychology·2026
Same author

Dopamine D<sub>4</sub> receptor activation preserves morphine analgesia and attenuates tolerance by enforcing inhibitory spinal tone in rats.

The journal of pain·2026
Same author

African Green Monkeys Respond to Synthetic Aβ Oligomers with Persistent Alzheimer's-like Activation.

bioRxiv : the preprint server for biology·2025
Same author

Food and the brain: Neural and endocrine control of feeding, metabolism, and reproduction.

Journal of neuroendocrinology·2025
Same author

Proteomic Signatures of Epigenetic Age in African Green Monkey Cerebrospinal Fluid and Plasma.

Aging cell·2025
Same author

Bridging the gap: Ghrelin and the female stress response to acute non-discriminatory social defeat.

Neuroscience·2025

Uncoupling protein 2 (UCP2) is vital for normal dopamine function in the brain. Reduced UCP2 levels may increase susceptibility to Parkinson's disease environmental factors.

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Neurodegenerative Diseases

Background:

  • Uncoupling protein 2 (UCP2) is recognized for its neuroprotective role in neurological disorders like Parkinson's disease.
  • The specific role of UCP2 in the normal functioning of the nigrostriatal dopamine system remains largely unexplored.

Purpose of the Study:

  • To investigate the hypothesis that UCP2 plays a role in the normal function of the nigrostriatal dopamine pathway.
  • To determine if UCP2 deficiency impacts dopamine turnover, neuronal markers, and locomotor behavior.

Main Methods:

  • Utilized UCP2-knockout (KO) mice and wild-type (WT) controls.
  • Assessed striatal dopamine turnover using the 3,4-dihydoxyphenylacetic acid/dopamine (DOPAC/DA) ratio.
  • Quantified tyrosine hydroxylase (TH) and dopamine transporter (DAT) immunoreactivity (IR) in specific brain regions.

Related Experiment Videos

  • Evaluated locomotor activity, including movement distance, velocity, and rest time.

    • Main Results:

    • UCP2-KO mice showed reduced striatal dopamine turnover (DOPAC/DA ratio).
    • Significant reductions in TH immunoreactivity were observed in the substantia nigra pars compacta (SNc), reticulata, striatum, and nucleus accumbens of UCP2-KO mice.
    • DAT immunoreactivity was decreased in the SNc of UCP2-KO mice.
    • UCP2-KO mice exhibited impaired locomotor function, characterized by reduced movement distance and velocity, and increased rest time compared to WT controls.

    Conclusions:

    • UCP2 is essential for maintaining normal nigrostriatal dopamine neuronal function.
    • Deficits in UCP2 may compromise dopamine system integrity, potentially contributing to Parkinson's disease pathogenesis.
    • Reduced UCP2 levels could predispose individuals to environmentally triggered Parkinson's disease.